Methods: All patients with asthma underwent immediate cutaneous testing including prick (epicutaneous) with a mix of Aspergillus species and if negative, intradermal at 1000 PNU/mL, Aspergillus fumigatus (Af). Sera were analyzed for total IgE (elevated is $417 kU/L) by Phadia ImmunoCap, anti-Af IgE and anti-Af IgG (ABPA range $ 2.0) ELISA, and precipitating antibodies. HRCT of the lungs was ordered next if serology was positive (diagnostic criteria for ABPA required total IgE $ 417 kU/L and both anti-Af IgE and IgG $ 2.0 compared to sera from skin test 1 patients with asthma without ABPA). To avoid bias from patients examined by the author, data were compared using screening from 5 other faculty in the same clinic. Results: From 2000 to 2010, 864 skin test 1 patients underwent serologic testing for ABPA from which 81 (9.4%) were diagnostic for ABPA, and in this group, precipitins were positive in 42/81. To address referral bias in screened patients of the author, diagnostic criteria were positive in 49/208 (23.5%) patients of the author versus 32/656 (4.8%) of other allergy-immunology faculty. In addition, some 74/884 (8.6%) patients had total IgE $ 417 kU/L and either anti-Af IgE or IgG $ 2.0, implying an overall at risk for ABPA population of 155/864 (17.9%). The highest total IgE recorded in a non-ABPA patient with asthma was 192,100 kU/L. Conclusions: Using total IgE and ELISA determinations to discriminate ABPA from skin test 1 asthma sera, 9.4% of patients had diagnostic evidence for APBA. Using data from faculty, presumably with less referral bias than the author, results in 4.8% patients with classic diagnostic criteria. This rate conservatively translates into a minimum of approximately 1.2% of patients with persistent asthma having APBA in the upper Midwestern US. The combination of elevated total IgE and precipitins but not elevated anti-Af IgE or IgG in this population has little/no value in diagnosis. Background: Sleep-disordered breathing (SDB) has been studied in obese adults but there are few studies on adolescents. This study analyzed the frequency of SDB in obese adolescents and controls with and without asthma. Methods: A cross-sectional comparative study, 27 obese adolescents 10 to 18 years old with body mass index (BMI) $ 95th percentile, of whom 17 (43%) had mild intermittent asthma (MIA) according to GINA 2005 guidelines and 23 (57%) without asthma, plus a group of 20 eutrophics adolescents (BMI ¼ percentile 50th-84th), 50% (n ¼ 10) with MIA and 50% (n ¼ 10) healthy. All patients underwent overnight polysomnography, primary snoring (PS) was diagnosed with recording of snoring and apnea/hypopnea index (AHI) ,1 and sleep apnea /hypopnea syndrome (SAHS) with an AHI $ 1 plus oxygen desaturations .4% baseline, bradycardia or tachycardia. We obtained measures of central tendency, dispersion and t student test for different groups. Results: In obese adolescents with and without asthma SAHS was found in 72.5% (n ¼ 29), PS was diagnosed in 20% (n ¼ 8) and the subgroup analysis of obese show that same number of asthmatic and non asthmatic had SAHS (70.5%, 74%, respectively). The subgroup analysis of asthmatics and healthy eutrophic had SAHS (60% (n ¼ 6), 0% (n ¼ 0) respectively. Globally AHI in the obese group was 2.05 6 3.48 compared to healthy eutrophic (0.40 6 0.26) with P ¼ 0.0016, significant differences were obtained in the analysis of subgroups: the IAH in obese adolescents with asthma (3.41 6 3.47) and obese without asthma (2.60 6 2.55) with P ¼ 0.7017. In the eutrophic group differences there were significant differences: eutrophic asthmatics (IAH: 2.15 6 0.26) and 0.40 6 0.26 healthy eutrophic P ¼ 0.0047. Conclusions: SDB is more common in obese adolescents. In eutrophic asthmatic adolescents SAHS was more frequent than in healthy, probably by the presence of co-morbidities such as rhinitis, hypertrophy of tonsils and all patients were classified as MIA. Adolescents who are obese have an increased risk of SDB compared with the group of healthy adolescents. ; P , 0.0001 by 2-tailed, unpaired Student's t tests with Bonferroni corrections). Receiver-operator curves identified 2 as the threshold for positive MRC Scores in Cohort 1. This indicated 54% of CFS, but only 3% of controls, had significant Dyspnea. In Cohort 2, the threshold Dyspnea Severity Score of 4 indicated shortness of breath in 67% of CFS and 23% of these controls. Cohort 2 Dyspnea Scores were higher for CFS (7.80 [6.60-9.00]) than controls (2.40 [1.60-3.20]; P , 0.0001). CFS had significantly worse fatigue, other CFS defining criteria and quality of life compared to controls. Although CFS had worse depressive affect and anxiety scores, only the controls showed correlations with Dyspnea Score. Pulmonary function was normal in CFS, but Borg scores and sensations of chest pain and dizziness were significantly greater during testing than controls. TLC was normal except for 2 of 16 CFS who had hyperinflation. A general linear model of Cohort 2 CFS responses linked Dyspnea Scores with rapid heart rate, chest pain and dizziness. Conclusions: Sensory hypersensitivity without airflow limitation contributed to Dyspnea in CFS. Correlates of Dyspnea in controls were distinct from CFS suggesting different mechanisms. Background: Allergic inflammation commonly affects the upper and lower airways concurrently. Although allergic nasal and pulmonary effects have been well described, laryngeal effects are not well understood. In this study we investigated the incidence of allergy in patients with benign lesions of the vocal cords and types of allergens causing these reactions. Methods: The study was approved by the local ethics committee, and written consent was obtained from all patients. A questionnaire made by the investigators taking the latest literature data into consideration were used during the study. Laryngeal examination was done with videolaryngostroboscopy and
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